|Last Price||Today's Change||52-Week Range||Trading Volume|
|58.54||-0.42 (-0.71%)||52.49 - 63.62||13.1 million (Above Avg)|
Market data as of 4:01PM 02/27/15. Quotes are delayed by at least 15 min.
New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe/simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions
02/25/2015 8:00 AM ET
Merck Announces Second-Quarter 2015 Dividend
02/24/2015 12:51 PM ET